Treatment Of Chronic Lymphocytic Leukemia Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GMAB | F | Genmab A/S | 0.88 | |
EGRX | F | Eagle Pharmaceuticals, Inc. | 18.75 | |
TEVA | D | Teva Pharmaceutical Industries | 0.23 |
Related Industries: Drug Manufacturers - Specialty & Generic Long-Term Care Facilities
Related Stock Lists:
Chronic Lymphocytic Leukemia
Lymphocytic Leukemia
Lymphoma
Medicine
Cancer
Drugs
Multiple Sclerosis
Parkinson's Disease
Pharmaceutical
Active Pharmaceutical Ingredients
Acute Myeloid Leukemia
Advanced Cancer
Advanced Cancers
Allergy
Amyloid
Amyloidosis
Angioplasty
Antibodies
Antibody Drug Conjugate
Asthma
Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Chronic Lymphocytic Leukemia stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ISRA | A | Market Vectors Israel ETF | 8.64 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 3.9 | |
THNR | F | Amplify Weight Loss Drug & Treatment ETF | 3.84 | |
PPH | D | Market Vectors Pharmaceutical ETF | 3.65 | |
FBT | C | First Trust Amex Biotech Index Fund | 3.04 |
Compare ETFs
Related Industries:
Drug Manufacturers - Specialty & Generic
Long-Term Care Facilities
Related Stock Lists:
Chronic Lymphocytic Leukemia
Lymphocytic Leukemia
Lymphoma
Medicine
Cancer
Drugs
Multiple Sclerosis
Parkinson's Disease
Pharmaceutical
Active Pharmaceutical Ingredients
Acute Myeloid Leukemia
Advanced Cancer
Advanced Cancers
Allergy
Amyloid
Amyloidosis
Angioplasty
Antibodies
Antibody Drug Conjugate
Asthma
- Treatment Of Chronic Lymphocytic Leukemia
Treatment of chronic lymphocytic leukemia (CLL) depends on the stage of the disease and the patient's age and overall health. Treatment options may include watchful waiting, chemotherapy, targeted therapy, radiation therapy, and stem cell transplant.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles